专题：Estrogen and related hormone effects

This cluster of papers explores the mechanisms of estrogen receptor signaling, with a focus on its role in breast cancer, interactions with glucocorticoids, and the effects of various drugs such as tamoxifen and aromatase inhibitors. It delves into the molecular pathways, gene regulation, and coactivator/coregulator dynamics involved in estrogen signaling.
最新文献
Switching to camizestrant at ESR1 mutation emergence before disease progression during first-line treatment of hormone receptor-positive advanced breast cancer (SERENA-6): extended analysis of a double-blind, placebo-controlled, randomised, phase 3 trial

article Full Text OpenAlex

Insights Into Vepdegestrant (ARV‐471): The First‐in‐Class Estrogen Receptor Proteolysis‐Targeting Chimera Approaching Food and Drug Administration Approval for Breast Cancer

review Full Text OpenAlex

LNG-IUD and breast cancer: Number 2 – 2026

article Full Text OpenAlex

Advances in the mechanism for steroid-induced osteonecrosis of the femoral head

review Full Text OpenAlex

Knowledge gaps and research priorities to understand sex differences in immunity

review Full Text OpenAlex

Epigenetic Mechanisms of Reproductive Dysfunction Induced by Endocrine-Disrupting Chemicals: Evidence From Molecular Studies

review Full Text OpenAlex

Menopausal hormone treatment and breast cancer

review Full Text OpenAlex

Emotional and cognitive effects of menopause and hormone replacement therapy

article Full Text OpenAlex

International Menopause Society (IMS) recommendations and key messages on women’s midlife health and menopause

article Full Text OpenAlex

Menopause hormone therapy and risk of mild cognitive impairment or dementia: a systematic review and meta-analysis

review Full Text OpenAlex

近5年高被引文献
The 2022 hormone therapy position statement of The North American Menopause Society

article Full Text OpenAlex 973 FWCI120.1775

International Journal on Biological Sciences

paratext Full Text OpenAlex 875 FWCI0

Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial

article Full Text OpenAlex 777 FWCI95.3221

Osteoporosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover

review Full Text OpenAlex 594 FWCI24.2704

A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer

review Full Text OpenAlex 387 FWCI14.977

Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial

article Full Text OpenAlex 358 FWCI44.0073

Sex hormone signaling and regulation of immune function

review Full Text OpenAlex 348 FWCI13.4677

Role of estrogen receptors in health and disease

review Full Text OpenAlex 339 FWCI10.1218

Menopause transition: Physiology and symptoms

article Full Text OpenAlex 331 FWCI43.235

The 2023 nonhormone therapy position statement of The North American Menopause Society

article Full Text OpenAlex 321 FWCI66.0014